Susann Meyer

Home >> Articles by: Susann Meyer >> Page 126
02.05.2022
Possible biomarker for Parkinson’s discovered using new MRI method
Researchers and MBExC members at the Max Planck Institute (MPI) for Multidisciplinary Sciences, the University Medical Center Göttingen (UMG), and the German Center for Neurodegenerative Diseases (DZNE) have used this insight in a first step to develop a new diagnostics approach.
02.05.2022
HAX1-dependent control of mitochondrial proteostasis governs neutrophil granulocyte differentiation
Fan Y, Murgia M, Linder MI, Mizoguchi Y, Wang C, Łyszkiewicz M, Ziȩtara N, Liu Y, Frenz S, Sciuccati G, Partida-Gaytan A, Alizadeh Z, Rezaei N, Rehling P, Dennerlein S, Mann M, Klein C
25.04.2022
Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes
Chegão A, Guarda M, Alexandre BM, Shvachiy L, Temido-Ferreira M, Marques-Morgado I, Fernandes Gomes B, Matthiesen R, Lopes LV, Florindo PR, Gomes RA, Gomes-Alves P, Coelho JE, Outeiro TF, Vicente Miranda H
21.04.2022
A Reliable Approach for Revealing Molecular Targets in Secondary Ion Mass Spectrometry
Li F, Fornasiero EF, Dankovich TM, Kluever V, Rizzoli SO
15.04.2022
Cln5 represents a new type of cysteine-based S-depalmitoylase linked to neurodegeneration
Luebben AV, Bender D, Becker S, Crowther LM, Erven I, Hofmann K, Söding J, Klemp H, Bellotti C, Stäuble A, Qiu T, Kathayat RS, Dickinson BC, Gärtner J, Sheldrick GM, Krätzner R, Steinfeld R
14.04.2022
A new tool for optogenetics: human receptor for studying cell function with light
Scientists of the University Medical Center Göttingen identify the human OPN5 receptor as a new target to activate cells and to study the principles of how cells communicate with each […]
X
EN DE
X
X